Skip To Main Content

Right Side

Landing Nav

Breadcrumb

The core of atopy is a Type I hypersensitivity reaction driven by a Type 2 immune response.

: Systemic immune priming eventually leads to upper and lower airway inflammation. 3. Key Management Strategies

: Often the first sign in infancy, caused by skin barrier defects (e.g., filaggrin mutations) that allow for epicutaneous allergen sensitization.

While there is currently no cure, management focuses on controlling inflammation and restoring barrier function. Atopy - StatPearls - NCBI Bookshelf - NIH

: Antigen-presenting cells perceive allergens (like pollen or dust mites) as danger signals, activating TH2 or ILC2 cells.